Introduction: Monophasic and biphasic hyaluronic acid gels differ in phase structure, and that difference shapes how each gel carries volume in body contouring.
When two body-area gels sit side by side, both labels may simply say "hyaluronic acid." The word that actually separates them is phase — whether the cross-linked polymer forms one continuous mass or a suspension of particles floating in a liquid carrier. That single material decision changes how a gel resists pressure, how it feels as it goes in, and how it settles into deep tissue. For anyone comparing body-area volume products, reading phase structure first makes the rest of a specification sheet far easier to interpret.
Hyaluronic acid is a long-chain polysaccharide that human tissue already contains, which is why it integrates well and is eventually broken down through normal metabolic pathways. On its own, though, a plain HA solution clears within days. Manufacturers stabilize it by cross-linking the chains with a reagent such as BDDE, creating a three-dimensional network that holds water and resists enzymatic breakdown. Phase structure describes what happens to that network afterwards: whether it is kept as one continuous piece, or broken into fragments and suspended in fluid. A monophasic gel keeps the cross-linked network as a single, continuous matrix. Nothing is sieved or ground into particles, so the material behaves like one cohesive block rather than a collection of separate units. A biphasic gel takes the opposite route: the cross-linked gel is fragmented into particles, and those particles are dispersed in a carrier of uncross-linked or lightly cross-linked HA fluid. The result is two distinct phases inside the same syringe — solid granules plus liquid medium — which is exactly what the name describes. The practical difference shows up immediately in handling. Monophasic gels feel smooth and uniform, with a firm, springy resistance that builds as pressure is applied. Biphasic gels often feel more like a flowing suspension: the initial resistance is lower, and the texture reads as granular or sandy as the particles pass through. Neither feel is a defect. Each one is the physical signature of how the gel is built, and each has clinical territory where it performs well.
Body areas are not the same environment as the mid-dermis of a cheek. Subcutaneous fat is thick, the tissue moves with every step, and in areas such as the buttock the material sits under direct body weight. Anything placed there has to hold its shape against sustained mechanical load rather than simply filling a static crease. That requirement is where the continuous network of a monophasic gel becomes relevant.
Cohesivity is the force that keeps a gel sticking to itself. In a monophasic gel, that force runs through the entire matrix, so when surrounding tissue pushes or shears against the material, it tends to move as one unit instead of separating into smaller fragments. Elasticity — often written as G' — is the gel's ability to push back and recover its shape after deformation. High cohesivity combined with high elasticity is what allows a gel to maintain projection in a moving, load-bearing area rather than spreading into a flat layer. No gel structure guarantees that a filler stays exactly where it is placed, but a continuous cohesive network is the design feature that works in that direction.
The firm side of monophasic body gels comes from two variables: how densely the polymer chains are cross-linked, and how much HA is packed into each millilitre. More cross-linking and higher concentration produce a denser network that resists compression and enzymatic breakdown for longer. Published clinical discussion of high-density monophasic gels centres on this deep structural support role, where volume needs to remain where it was placed. Product examples make the concept concrete: BELLA Sub-Skin is described as a high-density monophasic cohesive gel supplied in 10ml/box and 20ml/box formats for subcutaneous or supraperiosteal body placement, so the packaging itself reflects the larger volumes body areas demand. Stiffness, concentration and cross-linker level vary by product, so two monophasic gels can still feel noticeably different in the syringe.
In a biphasic gel, the carrier fluid and the particles do not behave identically. The carrier is thinner, so it tends to move first and spread further from the point of placement, while the particles follow and settle as discrete units. In practice this produces a gel that flows more easily at the start of a push and then offers a different resistance as the granules pass through the needle or cannula. For superficial and mid-dermal work, that flow profile is often an advantage: less force is needed, and the material spreads smoothly across a wider area. The trade-off appears when the target is a large body area under load. A granular suspension has more internal interfaces — boundaries between particles, and between particles and carrier — and those boundaries give the material more ways to shift relative to itself when tissue presses on it. The carrier also tends to be cleared faster than the cross-linked particles, which can leave a treated area feeling softer sooner than expected. None of this makes biphasic gels a lesser material. It simply means the phase structure suits different jobs, usually finer correction rather than bulk deep support. Handling also differs in ways injectors notice. Monophasic gels often demand steadier, more deliberate pressure and reward slow, controlled placement because the mass stays together as it travels. Biphasic gels can feel quicker to deliver but may need more attention to smoothing and distribution, since carrier and particles do not move as one. Both behaviours trace back to the same question: is the material a single continuous network, or a suspension of separate units in fluid?
Phase structure is the fastest way to predict how a hyaluronic acid body filler will behave before it ever reaches the tissue. A continuous monophasic network gives cohesion, elastic push-back and denser load-bearing support — the qualities that matter in deep subcutaneous and supraperiosteal body placement. A biphasic suspension gives easier flow and a granular texture that suits finer, more superficial correction. Neither wins universally, because cross-linking density, HA concentration and injection technique all shape the finished result. Reading phase, density and format together tells a far more accurate story than a label alone, and product information such as the BELLA Sub-Skin specification gives a useful reference point for what a high-density monophasic body gel looks like on paper.
A：The difference is phase structure. A monophasic gel keeps its cross-linked hyaluronic acid network as one continuous matrix, so the material behaves as a single cohesive mass. A biphasic gel fragments that cross-linked network into particles and suspends them in a fluid hyaluronic acid carrier, producing two phases inside the syringe: solid granules plus liquid medium. That structural choice drives the differences in injection feel, spread pattern and how the gel resists pressure once placed.
A：Body areas combine thick subcutaneous tissue, constant movement and, in places such as the buttock, direct body weight. A continuous monophasic network holds together under that kind of load, with cohesion keeping the mass intact and elasticity helping it retain projection instead of flattening. High-density monophasic gels are discussed in clinical literature specifically for deep structural support, which matches the volume and stability demands of large body-area contouring.
A：Yes. BELLA Sub-Skin is described as a high-density monophasic cohesive gel intended for subcutaneous or supraperiosteal body placement, and it is supplied in 10ml/box and 20ml/box formats that suit larger body-area volumes. Exact rheology, HA concentration and cross-linker level are formulation-specific, so the product's own technical documentation is the right place to confirm those parameters.
Monophasic and biphasic gel structure context - PMC
Clinical consensus on high-density monophasic gels - PMC
Hyaluronic acid: A key molecule in skin aging - PMC
